CanSino Biologics Shares Rose 380% As COVID-19 Vaccine Promise Emerges
May 21, 2020 at 08:17 AM EDT
CanSino Biologics Inc. a Chinese vaccine maker, has emerged as the rising star of the Hong Kong market after its COVID-19 clinical trial application was approved by Health Canada, the country's federal health policy department.
